All Stories

  1. Impact of antibiotics on membrane vesicle production in Group B Streptococcus
  2. Human Milk Oligosaccharides Mediate the Host–Microbe Interface in a Model Vaginal Community
  3. Group B Streptococcal Membrane Vesicles Induce Proinflammatory Cytokine Production and Are Sensed in an NLRP3 Inflammasome-Dependent Mechanism in a Human Macrophage-like Cell Line
  4. Selection of antibiotic-resistant bacterial populations in the dairy cow gut following intramuscular ceftiofur treatment for metritis
  5. Untargeted metabolomics and metagenomics reveal signatures for intramammary ceftiofur treatment and lactation stage in the cattle hindgut
  6. Shifts in the functional capacity and metabolite composition of the gut microbiome during recovery from enteric infection
  7. Intrapartum antibiotic prophylaxis selects for mutators in group B streptococci among persistently colonized patients
  8. Editorial: When streptococci seize the opportunity: identifying how manipulation of host inflammatory signaling impacts pathogenesis in streptococcal infections
  9. Environmental Toxicant Exposure Paralyzes Human Placental Macrophage Responses to Microbial Threat
  10. Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
  11. Recovery of the gut microbiome following enteric infection and persistence of antimicrobial resistance genes in specific microbial hosts
  12. The Utility of Human Milk Oligosaccharides against Group B Streptococcus Infections of Reproductive Tissues and Cognate Adverse Pregnancy Outcomes
  13. Pangenomic analyses of antibiotic-resistant Campylobacter jejuni reveal unique lineage distributions and epidemiological associations
  14. Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
  15. Whole-Genome Sequencing of Shiga Toxin-Producing Escherichia coli for Characterization and Outbreak Investigation
  16. Anti‐biofilm Activity of Human Milk Oligosaccharides in Clinical Strains of Streptococcus agalactiae with Diverse Capsular and Sequence Types
  17. Recovery of the gut microbiome following enteric infection and persistence of antimicrobial resistance genes in specific microbial hosts
  18. Streptococcus agalactiae npx Is Required for Survival in Human Placental Macrophages and Full Virulence in a Model of Ascending Vaginal Infection during Pregnancy
  19. Streptococcus agalactiae cadD Is Critical for Pathogenesis in the Invertebrate Galleria mellonella Model
  20. Editorial: Women and clinical microbiology 2021
  21. Streptococcus agalactiae npxis required for survival in human placental macrophages and full virulence in a model of ascending vaginal infection during pregnancy
  22. Streptococcus agalactiae cadD alleviates metal stress and promotes intracellular survival in macrophages and ascending infection during pregnancy
  23. Group B streptococcal membrane vesicles induce proinflammatory cytokine production and are sensed in an NLRP3 inflammasome-dependent mechanism in human macrophages
  24. Zoonotic Transmission of Campylobacter jejuni to Caretakers From Sick Pen Calves Carrying a Mixed Population of Strains With and Without Guillain Barré Syndrome-Associated Lipooligosaccharide Loci
  25. The antimicrobial activity of zinc against group B Streptococcus is strain-dependent across diverse sequence types, capsular serotypes, and invasive versus colonizing isolates
  26. Nitric Oxide Induced stx2 Expression Is Inhibited by the Nitric Oxide Reductase, NorV, in a Clade 8 Escherichia coli O157:H7 Outbreak Strain
  27. Galacto‐Oligosaccharide Supplementation Modulates Pathogen‐Commensal Competition between Streptococcus agalactiae and Streptococcus salivarius
  28. Antibiofilm Activity of Human Milk Oligosaccharides against Multidrug Resistant and Susceptible Isolates of Acinetobacter baumannii
  29. Production and Composition of Group B Streptococcal Membrane Vesicles Vary Across Diverse Lineages
  30. Comparing gut resistome composition among patients with acute Campylobacter infections and healthy family members
  31. Genomic analysis of shiga toxin-containing Escherichia coli O157:H7 isolated from Argentinean cattle
  32. Antibiotic Susceptibility Profiles and Frequency of Resistance Genes in Clinical Shiga Toxin-Producing Escherichia coli Isolates from Michigan over a 14-Year Period
  33. Analysis of Susceptibility to the Antimicrobial and Anti-Biofilm Activity of Human Milk Lactoferrin in Clinical Strains of Streptococcus agalactiae With Diverse Capsular and Sequence Types
  34. Production and composition of group B streptococcal membrane vesicles varies across diverse lineages
  35. Characterizing the Cattle Gut Microbiome in Farms with a High and Low Prevalence of Shiga Toxin Producing Escherichia coli
  36. Epidemiologic Associations Vary Between Tetracycline and Fluoroquinolone Resistant Campylobacter jejuni Infections
  37. Variability in the Occupancy of Escherichia coli O157 Integration Sites by Shiga Toxin-Encoding Prophages
  38. Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates
  39. Group B Streptococcus cpsE Is Required for Serotype V Capsule Production and Aids in Biofilm Formation and Ascending Infection of the Reproductive Tract during Pregnancy
  40. Distinct Group B Streptococcus Sequence and Capsule Types Differentially Impact Macrophage Stress and Inflammatory Signaling Responses
  41. Antibacterial and Anti‐biofilm Activity of the Human Breast Milk Glycoprotein Lactoferrin against Group B Streptococcus
  42. Population structure and genetic diversity of non-O157 Shiga toxin-producing Escherichia coli (STEC) clinical isolates from Michigan
  43. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee
  44. Vitamin D and Streptococci: The Interface of Nutrition, Host Immune Response, and Antimicrobial Activity in Response to Infection
  45. The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes
  46. Genetic and Phenotypic Factors Associated with Persistent Shedding of Shiga Toxin-Producing Escherichia coli by Beef Cattle
  47. Lactobacillus strains vary in their ability to interact with human endometrial stromal cells
  48. Effects of a high fat diet on gut microbiome dysbiosis in a mouse model of Gulf War Illness
  49. A Solution to Antifolate Resistance in Group B Streptococcus : Untargeted Metabolomics Identifies Human Milk Oligosaccharide-Induced Perturbations That Result in Potentiation of Trimethoprim
  50. Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections
  51. Genetic Diversity of Non-O157 Shiga Toxin-Producing Escherichia coli Recovered From Patients in Michigan and Connecticut
  52. Modulation of Death and Inflammatory Signaling in Decidual Stromal Cells following Exposure to Group B Streptococcus
  53. Increasing Frequencies of Antibiotic Resistant Non-typhoidal Salmonella Infections in Michigan and Risk Factors for Disease
  54. Genetically distinct Group B Streptococcus strains induce varying macrophage cytokine responses
  55. Population Gene Introgression and High Genome Plasticity for the Zoonotic Pathogen Streptococcus agalactiae
  56. Raman microspectroscopy differentiates perinatal pathogens on ex vivo infected human fetal membrane tissues
  57. Protein kinase D mediates inflammatory responses of human placental macrophages to Group B Streptococcus
  58. Investigation of the Role That NADH Peroxidase Plays in Oxidative Stress Survival in Group B Streptococcus
  59. 2011. Identification of Streptococcus agalactiae on Human Fetal Membrane Tissues Using Raman Microspectroscopy
  60. Variation in Macrophage Phagocytosis of Streptococcus agalactiae Does Not Reflect Bacterial Capsular Serotype, Multilocus Sequence Type or Association with Invasive Infection
  61. Prevalence and characteristics of Shiga toxin-producing Escherichia coli in finishing pigs: Implications on public health
  62. A Nonhemolytic Group B Streptococcus Strain Exhibits Hypervirulence
  63. Genome Sequences of 34 Shiga Toxin-Producing Escherichia coli Isolates from Swine and Other Sources
  64. Group B streptococcal colonization and transmission dynamics in pregnant women and their newborns in Nigeria: implications for prevention strategies
  65. Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA
  66. Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection
  67. Comparing the Genetic Diversity and Antimicrobial Resistance Profiles of Campylobacter jejuni Recovered from Cattle and Humans
  68. Intestinal Microbial Community Dynamics of White-Tailed Deer (Odocoileus virginianus) in an Agroecosystem
  69. Group B Streptococcus Induces Neutrophil Recruitment to Gestational Tissues and Elaboration of Extracellular Traps and Nutritional Immunity
  70. Contribution of the RgfD Quorum Sensing Peptide to rgf Regulation and Host Cell Association in Group B Streptococcus
  71. Bovine Leukemia Virus and Mycobacterium avium subsp. paratuberculosis Are Not Associated with Shiga Toxin–Producing Escherichia coli Shedding in Cattle
  72. Genetic Variation in Shiga Toxin-producing Escherichia coli Recovered from Patients in Michigan and Connecticut
  73. High prevalence of clade 8 Escherichia coli O157:H7 isolated from retail meat and butcher shop environment
  74. Differing mechanisms of surviving phagosomal stress among group B Streptococcus strains of varying genotypes
  75. Factors associated with increasing campylobacteriosis incidence in Michigan, 2004–2013
  76. Factors Associated with Shiga Toxin-Producing Escherichia coli Shedding by Dairy and Beef Cattle
  77. Association between genotypic diversity and biofilm production in group B Streptococcus
  78. Impact of age and sex on the composition and abundance of the intestinal microbiota in individuals with and without enteric infections
  79. Antimicrobial Susceptibility Profiles of Human Campylobacter jejuni Isolates and Association with Phylogenetic Lineages
  80. Genomic Analysis ofSalmonella entericaSerovar Typhimurium Characterizes Strain Diversity for Recent U.S. Salmonellosis Cases and Identifies Mutations Linked to Loss of Fitness under Nitrosative and Oxidative Stress
  81. Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation
  82. Increasing incidence of non-O157 Shiga toxin-producing Escherichia coli (STEC) in Michigan and association with clinical illness
  83. Draft Genome Sequence of a DiarrheagenicMorganella morganiiIsolate
  84. Intestinal microbial communities associated with acute enteric infections and disease recovery
  85. Effect of feeding a direct-fed microbial on total and antimicrobial-resistant fecal coliform counts in preweaned dairy calves
  86. Within-Farm Changes in Dairy Farm-Associated Salmonella Subtypes and Comparison to Human Clinical Isolates in Michigan, 2000-2001 and 2009
  87. Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes
  88. Characterization of enteropathogenic and Shiga toxin-producing Escherichia coli in cattle and deer in a shared agroecosystem
  89. Corrigendum to “Exploiting the explosion of information associated with whole genome sequencing to tackle Shiga toxin-producing Escherichia coli (STEC) in global food production systems” [Int. J. Food Microbiol. 187 (2014) 57–72]
  90. Emergence of a hypervirulent neonatal pathogen
  91. Exploiting the explosion of information associated with whole genome sequencing to tackle Shiga toxin-producing Escherichia coli (STEC) in global food production systems
  92. Molecular Characterization of Shiga Toxin‐ProducingEscherichia coli
  93. Association and Virulence Gene Expression Vary among Serotype III Group B Streptococcus Isolates following Exposure to Decidual and Lung Epithelial Cells
  94. Diverse Virulence Gene Content of Shiga Toxin-Producing Escherichia coli from Finishing Swine
  95. Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspective
  96. Molecular Evolution of Enterohemorrhagic Escherichia coli and Application to Epidemiology
  97. Sepsis From the Gut: The Enteric Habitat of Bacteria That Cause Late-Onset Neonatal Bloodstream Infections
  98. Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans
  99. Shiga toxin-producingEscherichia coliin swine: the public health perspective
  100. Phylogenetic Clades 6 and 8 of Enterohemorrhagic Escherichia coli O157:H7 With Particular stx Subtypes are More Frequently Found in Isolates From Hemolytic Uremic Syndrome Patients Than From Asymptomatic Carriers
  101. Acquisition and persistence of antimicrobial-resistant bacteria isolated from dogs and cats admitted to a veterinary teaching hospital
  102. Whole-Genome Shotgun Sequencing of a Colonizing Multilocus Sequence Type 17 Streptococcus agalactiae Strain
  103. Correlation between In Vivo Biofilm Formation and Virulence Gene Expression in Escherichia coli O104:H4
  104. Draft Genome Sequences of the Diarrheagenic Escherichia coli Collection
  105. Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease
  106. The Evolution of Foodborne Pathogens
  107. Increased Adherence and Expression of Virulence Genes in a Lineage of Escherichia coli O157:H7 Commonly Associated with Human Infections
  108. Association of Group B Streptococcus Colonization and Bovine Exposure: A Prospective Cross-Sectional Cohort Study
  109. Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7
  110. Heat Waves, Impervious Surfaces, and Hospital Admissions among the Elderly in U.S. Cities
  111. Differential Expression of Virulence and Stress Fitness Genes between Escherichia coli O157:H7 Strains with Clinical or Bovine-Biased Genotypes
  112. Selection, Recombination, and Virulence Gene Diversity among Group B Streptococcal Genotypes
  113. Prevalence of the Operon Encoding Subtilase Cytotoxin in Non-O157 Shiga Toxin-Producing Escherichia coli Isolated from Humans in the United States
  114. Multilocus Sequence Types Associated with Neonatal Group B Streptococcal Sepsis and Meningitis in Canada
  115. Genetic Diversity and Antimicrobial Resistance in Group B Streptococcus Colonizing Young, Nonpregnant Women
  116. Genotypic Diversity and Serotype Distribution of Group B Streptococcus Isolated from Women Before and After Delivery
  117. Genetic Differentiation of Escherichia coli O157:H7 Clades Associated with Human Disease by Real-Time PCR
  118. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks
  119. Risk Factors for Group B Streptococcal Colonization: Potential for Different Transmission Systems by Capsular Type
  120. Surveillance for Shiga Toxin–producing Escherichia coli, Michigan, 2001–2005
  121. Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies
  122. Incidence and Duration of Group B Streptococcus by Serotype Among Male and Female College Students Living in a Single Dormitory
  123. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates
  124. Vaccination for Group B Streptococcus during pregnancy: Attitudes and concerns of women and health care providers
  125. Frequency of antimicrobial resistance among invasive and colonizing Group B Streptococcal isolates
  126. Incidence and Duration of Group B Streptococcus by Serotype among Male and Female College Students Living in a Single Dormitory
  127. DNA Polymorphism and Molecular Subtyping of the Capsular Gene Cluster of Group B Streptococcus
  128. Choosing an appropriate bacterial typing technique for epidemiologic studies
  129. Prevalence of Group B Streptococcus Colonization and Potential for Transmission by Casual Contact in Healthy Young Men and Women
  130. Comparison of DNA Dot Blot Hybridization and Lancefield Capillary Precipitin Methods for Group B Streptococcal Capsular Typing
  131. Group B Streptococcus acquisition among college students living in a single dormitory
  132. Molecular serotyping of Group B Streptococci (GBS) by PCR and DNA dot blot hybridization
  133. RE: "UROPATHOGENIC ESCHERICHIA COLI ARE MORE LIKELY THAN COMMENSAL E. COLI TO BE SHARED BETWEEN HETEROSEXUAL SEX PARTNERS"
  134. Molecular epidemiology of Streptococcus Agalactiae Group B Streptococcus
  135. Correlates of Antibiotic-Resistant Group B Streptococcus Isolated From Pregnant Women
  136. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women
  137. Uropathogenic Escherichia coli Are More Likely than Commensal E. coli to Be Shared between Heterosexual Sex Partners
  138. #89-S predictors of group b Streptococcus Colonization in healthy, young men and women
  139. Determinants of Co-Colonization with Group B Streptococcus Among Heterosexual College Couples
  140. Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli
  141. Group B Streptococcus Colonization in Male and Nonpregnant Female University Students: A Cross‐Sectional Prevalence Study
  142. Frequency of Antibiotic Resistance among Group B Streptococcus Isolated from Healthy College Students
  143. Prevalence of Known P-Fimbrial G Alleles inEscherichia coli and Identification of a New Adhesin Class
  144. Prevalence and co-colonization with group b streptococcus (Gbs) Among heterosexual college couples
  145. Molecular Epidemiologic Approaches to Urinary Tract Infection Gene Discovery in Uropathogenic Escherichia coli
  146. Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli